A new hope for India to curb vector-borne disease, the first indigenous malaria vaccine has reportedly shown excellent efficacy in the preclinical stage of development.
A sweet cherry flavour, including in breast milk, and easily dissovleable drug is now approved for the treatment of malaria in Infants under 5kg.
The Serum Institute of India in collaboration with the University of Oxford has manufactured a high efficacy malaria vaccine that was officially rolled out on Monday in Cote d'Ivoire in West Africa.
The first batch of malaria vaccines developed and manufactured by the Serum Institute of India was shipped to Africa, a country where malaria is endemic.
The World Health Organisation (WHO) has added a second malaria vaccine in their pre-qualified list. This is a huge stride in the battle against malaria especially in malaria endemic countries.
In a significant development in the fight against malaria, the World Health Organization (WHO) has given its approval to the R21/Matrix-M malaria vaccine.
Safeguarding children from malaria fever requires a combination of preventative measures, awareness, and timely action.
In countries that are tropical or subtropical, vector-borne diseases like malaria and dengue are more prone to spread. However, India will soon have its own medicine to treat the disease.
These 12 African countries are set to receive the first doses of the malaria vaccine during the last quarter of 2023 and start administering it to children by early 2024.
Researchers from the University of Oxford have reported new findings, booster dose of the candidate malaria vaccine, R21/Matrix-M Found "Vaccine booster dose at one year following a primary three-dose regime". The researchers report a vaccine efficacy of 80% in the higher-dose adjuvant group. No serious adverse events related to the vaccine were noted.
The new vaccine will give 80 per cent protection against malaria, Oxford did wonders, and India will make 100 million doses.
According to WHO data, there are high malarial locations in more than 30 countries. Therefore, this vaccine could protect more than 25 million children from malaria annually.
From launching of the World's first anti-malaria vaccine to CDC linking small turtles to Salmonella Outbreak in the US, here are five health news that made headlines today.
Anti-Malaria Vaccine: World's first anti-malarial vaccine is being prepared; know how effective the vaccine is.
While there have been antimalarial drugs to prevent malaria but this is the first time a vaccine has been approved by authorities against the disease. Here's everything you need to know about it.
According to WHO, after spending 30 years in the making, RTS,S has been developed as the first and to date the only vaccine to prevent malaria.
An experimental new malaria vaccine is offering potentially long-lasting immunity against the persistent parasite that sickens hundreds of millions of people each year, a study suggests.
A new study published in the journal Clinical Infectious Diseases has revealed that a new vaccine developed by scientists to provide protection against pregnancy-associated malaria was found safe in an early clinical trial.
A new hope for India to curb vector-borne disease, the first indigenous malaria vaccine has reportedly shown excellent efficacy in the preclinical stage of development.
A sweet cherry flavour, including in breast milk, and easily dissovleable drug is now approved for the treatment of malaria in Infants under 5kg.
The Serum Institute of India in collaboration with the University of Oxford has manufactured a high efficacy malaria vaccine that was officially rolled out on Monday in Cote d'Ivoire in West Africa.
The first batch of malaria vaccines developed and manufactured by the Serum Institute of India was shipped to Africa, a country where malaria is endemic.
The World Health Organisation (WHO) has added a second malaria vaccine in their pre-qualified list. This is a huge stride in the battle against malaria especially in malaria endemic countries.
In a significant development in the fight against malaria, the World Health Organization (WHO) has given its approval to the R21/Matrix-M malaria vaccine.
In countries that are tropical or subtropical, vector-borne diseases like malaria and dengue are more prone to spread. However, India will soon have its own medicine to treat the disease.
These 12 African countries are set to receive the first doses of the malaria vaccine during the last quarter of 2023 and start administering it to children by early 2024.
The new vaccine will give 80 per cent protection against malaria, Oxford did wonders, and India will make 100 million doses.
According to WHO data, there are high malarial locations in more than 30 countries. Therefore, this vaccine could protect more than 25 million children from malaria annually.
From launching of the World's first anti-malaria vaccine to CDC linking small turtles to Salmonella Outbreak in the US, here are five health news that made headlines today.
Anti-Malaria Vaccine: World's first anti-malarial vaccine is being prepared; know how effective the vaccine is.
While there have been antimalarial drugs to prevent malaria but this is the first time a vaccine has been approved by authorities against the disease. Here's everything you need to know about it.
According to WHO, after spending 30 years in the making, RTS,S has been developed as the first and to date the only vaccine to prevent malaria.
An experimental new malaria vaccine is offering potentially long-lasting immunity against the persistent parasite that sickens hundreds of millions of people each year, a study suggests.
A new study published in the journal Clinical Infectious Diseases has revealed that a new vaccine developed by scientists to provide protection against pregnancy-associated malaria was found safe in an early clinical trial.
PPT1 is an enzyme which helps in controlling both the mechanistic target of rapamycin (mTOR), a major regulator of growth in cancer cells, as well as a process called autophagy, a built-in resistance mechanism which allows cells to survive when under attack by breaking down unneeded parts and recycling them to stay alive.
As per scientists, wiping out mosquitoes from countries ravaged by malaria would not have a negative impact on any other native species.
Safeguarding children from malaria fever requires a combination of preventative measures, awareness, and timely action.
Researchers from the University of Oxford have reported new findings, booster dose of the candidate malaria vaccine, R21/Matrix-M Found "Vaccine booster dose at one year following a primary three-dose regime". The researchers report a vaccine efficacy of 80% in the higher-dose adjuvant group. No serious adverse events related to the vaccine were noted.
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Refresh Page